The Director General of Foreign Trade on 14th June 2021 has revised the export policy of Remdesivir injection and Remdesivir Active Pharmaceutical Ingredients (API).
The export of Remdesivir injections and APIs against the Advance Authorization shall no longer require a separate export authorisation or permission as, under the revised policy, the drug has been moved from ‘prohibited’ to ‘restricted’ category.